eNOS genotype-dependent correlation between whole blood lead and plasma nitric oxide products concentrations

Nitric Oxide - Biology and Chemistry

Volumn 14, Issue 1, 2006, Pages 58-64

  Barbosa Jr , Fernando ^a   Sandrim, Valeria C ^a   Uzuelli, Juliana A ^a   Gerlach, Raquel F ^a   Tanus Santos, Jose E ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Endothelial nitric oxide synthase; Genotype; Lead; Nitric oxide; Polymorphisms

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; GENOMIC DNA; LEAD; NITRIC OXIDE;

ADULT; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BLOOD; BLOOD ANALYSIS; BLOOD SAMPLING; CHEMOLUMINESCENCE; CIRCULATION; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LEAD BLOOD LEVEL; MALE; MASS SPECTROMETRY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADOLESCENT; ADULT; BASE SEQUENCE; DNA PRIMERS; FEMALE; GENOTYPE; HUMANS; LEAD; MALE; MIDDLE AGED; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC;

EID: 30344439825     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.niox.2005.09.007     Document Type: Article

References (39)

1. Agency for Toxic Substances and Disease Registry, Toxicological Profile for Lead. Atlanta, Ga: US Department of Health and Human Services, Public Health Services, (1999).
2. L. Moller, and T.S. Kristensen Blood lead as a cardiovascular risk factor Am. J. Epidemiol. 136 1992 1091 1100
3. A. Navas-Acien, E. Selvin, A.R. Sharrett, E. Calderon-Aranda, E. Silbergeld, and E. Guallar Lead, cadmium, smoking, and increased risk of peripheral arterial disease Circulation 109 2004 3196 3201
4. J.L. Pirkle, J. Schwartz, J.R. Landis, and W.R. Harlan The relationship between blood lead levels and blood pressure and its cardiovascular risk implications Am. J. Epidemiol. 121 1985 246 258
5. J. Schwartz Lead, blood pressure, and cardiovascular disease in men Arch. Environ. Health 50 1995 31 37
6. N.D. Vaziri, and D.A. Sica Lead-induced hypertension: role of oxidative stress Curr. Hypertens. Rep. 6 2004 314 320
7. H. Gurer-Orhan, H.U. Sabir, and H. Ozgunes Correlation between clinical indicators of lead poisoning and oxidative stress parameters in controls and lead-exposed workers Toxicology 195 2004 147 154
8. H. Gurer, and N. Ercal Can antioxidants be beneficial in the treatment of lead poisoning? Free Radic. Biol. Med. 29 2000 927 945
9. Z. Ni, S. Hou, C.H. Barton, and N.D. Vaziri Lead exposure raises superoxide and hydrogen peroxide in human endothelial and vascular smooth muscle cells Kidney Int. 66 2004 2329 2336
10. N.D. Vaziri, and Y. Ding Effect of lead on nitric oxide synthase expression in coronary endothelial cells : role of superoxide Hypertension 37 2001 223 226
11. J.P. Cooke, and V.J. Dzau Nitric oxide synthase: role in the genesis of vascular disease Annu. Rev. Med. 48 1997 489 509
12. A.D. Hingorani Polymorphisms in endothelial nitric oxide synthase and atherogenesis: John French Lecture 2000 Atherosclerosis 154 2001 521 527
13. J.E. Tanus-Santos, M. Desai, and D.A. Flockhart Effects of ethnicity on the distribution of clinically relevant endothelial nitric oxide variants Pharmacogenetics 11 2001 719 725
14. T.A. Fairchild, D. Fulton, J.T. Fontana, J.P. Gratton, T.J. McCabe, and W.C. Sessa Acidic hydrolysis as a mechanism for the cleavage of the Glu298Asp-variant of human endothelial nitric oxide synthase J. Biol. Chem. 30 2001 30
15. M. Nakayama, H. Yasue, M. Yoshimura, Y. Shimasaki, K. Kugiyama, H. Ogawa, T. Motoyama, Y. Saito, Y. Ogawa, and Y. Miyamoto T-786-C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm Circulation 99 1999 2864 2870
16. Y. Miyamoto, Y. Saito, M. Nakayama, Y. Shimasaki, T. Yoshimura, M. Yoshimura, M. Harada, N. Kajiyama, I. Kishimoto, and K. Kuwahara Replication protein A1 reduces transcription of the endothelial nitric oxide synthase gene containing a -786T-C mutation associated with coronary spastic angina Hum. Mol. Genet. 9 2000 2629 2637
17. M. Rosselli, B. Imthurn, P.J. Keller, E.K. Jackson, and R.K. Dubey Circulating nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17 beta-estradiol and norethisterone acetate. A two-year follow-up study Hypertension 25 1995 848 853
18. J.B. Hibbs Jr., C. Westenfelder, R. Taintor, Z. Vavrin, C. Kablitz, R.L. Baranowski, J.H. Ward, R.L. Menlove, M.P. McMurry, and J.P. Kushner Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy J. Clin. Invest. 89 1992 867 877
19. X.L. Wang, M.C. Mahaney, A.S. Sim, J. Wang, J. Blangero, L. Almasy, R.B. Badenhop, and D.E. Wilcken Genetic contribution of the endothelial constitutive nitric oxide synthase gene to plasma nitric oxide levels Arterioscler. Thromb. Vasc. Biol. 17 1997 3147 3153
20. C. Baylis, and P. Vallance Measurement of nitrite and nitrate levels in plasma and urine-what does this measure tell us about the activity of the endogenous nitric oxide system? Curr. Opin. Nephrol. Hypertens. 7 1998 59 62
21. S. Nagassaki, I.F. Metzger, D.C. Souza-Costa, A.S. Marroni, J.A. Uzuelli, and J.E. Tanus-Santos eNOS genotype is without effect on circulating nitrite/nitrate level in healthy male population Thromb. Res. 115 2005 375 379
22. I.F. Metzger, D.C. Souza-Costa, A.S. Marroni, S. Nagassaki, Z. Desta, D.A. Flockhart, and J.E. Tanus-Santos Endothelial nitric oxide synthase gene haplotypes associated with circulating concentrations of nitric oxide products in healthy men Pharmacogenomics 15 2005 565 570
23. N.D. Vaziri, K. Liang, and Y. Ding Increased nitric oxide inactivation by reactive oxygen species in lead-induced hypertension Kidney Int. 56 1999 1492 1498
24. J.E. Tanus-Santos, M. Desai, L.R. Deak, J.C. Pezzullo, D.R. Abernethy, D.A. Flockhart, and J.E. Freedman Effects of endothelial nitric oxide synthase gene polymorphisms on platelet function, nitric oxide release, and interactions with estradiol. Pharmacogenetics 12 2002 407 413
25. C.F. Sing, J.H. Stengard, and S.L. Kardia Genes, environment, and cardiovascular disease Arterioscler. Thromb. Vasc. Biol. 23 2003 1190 1196
26. K. Node, M. Kitakaze, H. Yoshikawa, H. Kosaka, and M. Hori Reduced plasma concentrations of nitrogen oxide in individuals with essential hypertension Hypertension 30 1997 405 408
27. W.I. Manton, S.J. Rothenberg, and M. Manalo The lead content of blood serum Environ. Res. 86 2001 263 273
28. Y. Zhou, R.A. Zanao, F. Barbosa, P.J. Parsons, and F.J. Krug Investigations on a W-Rh permanent modifier for the detection of Pb in blood by electrothermal atomic absorption spectrometry. Spectrochim. Acta. part B 57 2002 1291 1300
29. A. Schutz, I.A. Bergdahl, A. Ekholm, and S. Skerfving Measurement by ICP-MS of lead in plasma and whole blood of lead workers and controls Occup. Environ. Med. 53 1996 736 740
30. A.S. Marroni, I.F. Metzger, D.C. Souza-Costa, S. Nagassaki, V.C. Sandrim, R.X. Correa, F. Rios-Santos, and J.E. Tanus-Santos Consistent interethnic differences in the distribution of clinically relevant endothelial nitric oxide synthase (eNOS) genetic polymorphisms Nitric Oxide 12 2005 177 182
31. D.C. Souza-Costa, T. Zerbini, I.F. Metzger, J.B. Rocha, R.F. Gerlach, and J.E. Tanus-Santos L-Arginine attenuates acute pulmonary embolism-induced oxidative stress and pulmonary hypertension Nitric Oxide 12 2005 9 14
32. M.M. Castro, E. Rizzi, R.R. Rascado, S. Nagassaki, L.M. Bendhack, and J.E. Tanus-Santos Atorvastatin enhances sildenafil-induced vasodilation through nitric oxide-mediated mechanisms Eur. J. Pharmacol. 498 2004 189 194
33. X. Wang, J.E. Tanus-Santos, C.D. Reiter, A. Dejam, S. Shiva, R.D. Smith, N. Hogg, and M.T. Gladwin Biological activity of nitric oxide in the plasmatic compartment Proc. Natl. Acad. Sci. USA 101 2004 11477 11482
34. F. Barbosa Jr., J.E. Tanus-Santos, R.F. Gerlach, P.J. Parsons, Current needs and limitations on the use of biomarkers of internal dose to diagnose lead exposure., Environ Health Perspect (2005) (in press).
35. B.L. Gulson, J.G. Pounds, P. Mushak, B.J. Thomas, B. Gray, and M.J. Korsch Estimation of cumulative lead releases (lead flux) from the maternal skeleton during pregnancy and lactation J. Lab. Clin. Med. 134 1999 631 640
36. B.L. Gulson, C.W. Jameson, K.R. Mahaffey, K.J. Mizon, M.J. Korsch, and G. Vimpani Pregnancy increases mobilization of lead from maternal skeleton J. Lab. Clin. Med. 130 1997 51 62
37. B.L. Gulson, K.R. Mahaffey, C.W. Jameson, K.J. Mizon, M.J. Korsch, M.A. Cameron, and J.A. Eisman Mobilization of lead from the skeleton during the postnatal period is larger than during pregnancy J. Lab. Clin. Med. 131 1998 324 329
38. E.K. Silbergeld, J. Schwartz, and K. Mahaffey Lead and osteoporosis: mobilization of lead from bone in postmenopausal women Environ. Res. 47 1988 79 94
39. K. Theppeang, B.S. Schwartz, B.K. Lee, M.E. Lustberg, E.K. Silbergeld, K.T. Kelsey, P.J. Parsons, and A.C. Todd Associations of patella lead with polymorphisms in the vitamin D receptor, delta-aminolevulinic acid dehydratase and endothelial nitric oxide synthase genes J. Occup. Environ. Med. 46 2004 528 537